carbapenems has been researched along with bismuth tripotassium dicitrate in 1 studies
Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (bismuth tripotassium dicitrate) | Trials (bismuth tripotassium dicitrate) | Recent Studies (post-2010) (bismuth tripotassium dicitrate) |
---|---|---|---|---|---|
7,355 | 147 | 5,277 | 823 | 334 | 85 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, P; Ho, PL; Kao, RY; Lai, TP; Li, H; Ma, G; Sun, H; Wang, R; Woo, PC; Zhang, H | 1 |
1 other study(ies) available for carbapenems and bismuth tripotassium dicitrate
Article | Year |
---|---|
Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors.
Topics: Animals; Anti-Infective Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Bismuth; Carbapenems; Catalytic Domain; Crystallography, X-Ray; Dogs; Drug Evaluation, Preclinical; Evolution, Molecular; Female; Madin Darby Canine Kidney Cells; Mice, Inbred BALB C; Microbial Sensitivity Tests; Organometallic Compounds; Peritonitis; Zinc | 2018 |